![Raymond de Vre](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raymond de Vre
Director/Board Member at
CODEXIS, INC.
Net worth: 144 179 $ as of 2026-08-30
Profile
Dr. Raymond de Vre is an Independent Director at EQL Pharma AB, an Independent Director at Codexis, Inc. and a Chairman at PolyPeptide Laboratories A/S.
He is on the Board of Directors at EQL Pharma AB, Codexis, Inc. and Aurigene Oncology Ltd. Dr. de Vre was previously employed as a Chief Executive Officer by PolyPeptide Group AG, a Senior Vice President-Global Business Operations by Reddys Medicare Laboratories India Pvt Ltd., and a Partner by McKinsey & Co., Inc. He received his graduate degree from Université Libre de Bruxelles and a doctorate degree from Stanford University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CODEXIS, INC. 0.08% | 2026-06-16 | 84,811 ( 0.08% ) | 144 179 $ | 2026-08-30 |
Latest news about Raymond de Vre
Raymond de Vre active positions
| Companies | Position | Start |
|---|---|---|
| CODEXIS, INC. | Director/Board Member | 2024-11-06 |
| EQL PHARMA AB | Director/Board Member | 2024-12-31 |
Aurigene Oncology Ltd.
 Aurigene Oncology Ltd. BiotechnologyHealth Technology Operates as clinical stage biotechnology company | Director/Board Member | - |
PolyPeptide Laboratories A/S
 PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Chairman | - |
Former positions of Raymond de Vre
| Companies | Position | End |
|---|---|---|
| POLYPEPTIDE GROUP AG | Chief Executive Officer | 2023-01-29 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 2010-12-31 |
Training of Raymond de Vre
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
100
+
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EQL Pharma AB
 EQL Pharma AB Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic and specialty pharmaceutical products | Health Technology |
Aurigene Oncology Ltd.
Aurigene Oncology Ltd. BiotechnologyHealth Technology Operates as clinical stage biotechnology company | Health Technology |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Process Industries |
PolyPeptide Group AG
 PolyPeptide Group AG BiotechnologyHealth Technology Manufactures polypeptide and custom peptide synthesis | Health Technology |
- Stock Market
- Insiders
- Raymond de Vre
